{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:59:48Z","timestamp":1794491988863,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The importance of metal biology in neurodegenerative diseases such as Huntingtin Disease is well documented with evidence of direct interactions between metals such as copper, zinc, iron and manganese and mutant Huntingtin pathobiology. To date, it is unclear whether these interactions are observed in humans, how this impacts other metals, and how mutant Huntington alters homeostatic mechanisms governing levels of copper, zinc, iron and manganese in cerebrospinal fluid and blood in HD patients. Plasma and cerebrospinal fluid from control, pre-manifest, manifest and late manifest HD participants were collected as part of HD-Clarity. Levels of cerebrospinal fluid and plasma copper, zinc, iron and manganese were measured as well as levels of mutant Huntingtin and neurofilament in a sub-set of cerebrospinal fluid samples. We find that elevations in cerebrospinal fluid copper, manganese and zinc levels are altered early in disease prior to alterations in canonical biomarkers of HD although these changes are not present in plasma. We also evidence that CSF iron is elevated in manifest patients. The relationships between plasma and cerebrospinal fluid metal are altered based on disease stage. These findings demonstrate that there are alterations in metal biology selectively in the CSF which occur prior to changes in known canonical biomarkers of disease. Our work indicates that there are pathological changes related to alterations in metal biology in individuals without elevations in neurofilament and mutant Huntingtin.<\/jats:p>","DOI":"10.1038\/s41598-022-14169-y","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T13:02:57Z","timestamp":1655730177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Alterations in metal homeostasis occur prior to canonical markers in Huntington disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Anna C.","family":"Pfalzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakmook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Totten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Erikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"14169_CR1","volume-title":"Alzheimer\u2019s disease","author":"CA De Benedictis","year":"2019","unstructured":"De Benedictis, C. A., Vilella, A. & Grabrucker, A. M. The Role of Trace Metals in Alzheimer\u2019s Disease. In Alzheimer\u2019s disease (ed. Wisniewski, T.) (Codon Publications, 2019)."},{"key":"14169_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","volume":"120","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Fox, J., Thyagarajan, B. & Fox, J. H. Brain mitochondrial iron accumulates in Huntington\u2019s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically. Free Radic. Biol. Med. 120, 317\u2013329 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"14169_CR3","first-page":"339","volume":"19","author":"CR Cornett","year":"1998","unstructured":"Cornett, C. R., Markesbery, W. R. & Ehmann, W. D. Imbalances of trace elements related to oxidative damage in Alzheimer\u2019s disease brain. Neurotoxicology 19, 339\u2013345 (1998).","journal-title":"Neurotoxicology"},{"key":"14169_CR4","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1016\/S0021-9258(18)45643-8","volume":"262","author":"B Bendiak","year":"1987","unstructured":"Bendiak, B. & Schachter, H. Control of glycoprotein synthesis Kinetic mechanism, substrate specificity, and inhibition characteristics of UDP-N-acetylglucosamine:alpha-D-mannoside beta 1\u20132 N-acetylglucosaminyltransferase II from rat liver. J. Biol. Chem. 262, 5784\u20135790 (1987).","journal-title":"J. Biol. Chem."},{"key":"14169_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.sbi.2004.09.006","volume":"14","author":"B Ramakrishnan","year":"2004","unstructured":"Ramakrishnan, B., Boeggeman, E., Ramasamy, V. & Qasba, P. K. Structure and catalytic cycle of beta-1,4-galactosyltransferase. Curr. Opin. Struct. Biol. 14, 593\u2013600 (2004).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"14169_CR6","doi-asserted-by":"publisher","first-page":"14995","DOI":"10.1073\/pnas.1308535110","volume":"110","author":"G Xiao","year":"2013","unstructured":"Xiao, G., Fan, Q., Wang, X. & Zhou, B. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Proc. Natl. Acad. Sci. U. S. A. 110, 14995\u201315000 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14169_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","volume":"11","author":"RG Lucchini","year":"2009","unstructured":"Lucchini, R. G., Martin, C. J. & Doney, B. C. From manganism to manganese-induced Parkinsonism: A conceptual model based on the evolution of exposure. NeuroMol. Med. 11, 311\u2013321 (2009).","journal-title":"NeuroMol. Med."},{"key":"14169_CR8","volume-title":"StatPearls","author":"HS Chaudhry","year":"2021","unstructured":"Chaudhry, H. S. & Anilkumar, A. C. Wilson Disease. In StatPearls (StatPearls Publishing, 2021)."},{"key":"14169_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ejhg.2009.187","volume":"18","author":"Z T\u00fcmer","year":"2010","unstructured":"T\u00fcmer, Z. & M\u00f8ller, L. B. Menkes disease. Eur. J. Hum. Genet. EJHG 18, 511\u2013518 (2010).","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"14169_CR10","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1093\/hmg\/ddz209","volume":"28","author":"MR Bryan","year":"2019","unstructured":"Bryan, M. R. et al. Acute manganese treatment restores defective autophagic cargo loading in Huntington\u2019s disease cell lines. Hum. Mol. Genet. 28, 3825\u20133841 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"14169_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-319-60189-2_6","volume":"18","author":"MR Bryan","year":"2017","unstructured":"Bryan, M. R. & Bowman, A. B. Manganese and the insulin-IGF signaling network in Huntington\u2019s disease and other neurodegenerative disorders. Adv. Neurobiol. 18, 113\u2013142 (2017).","journal-title":"Adv. Neurobiol."},{"key":"14169_CR12","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbadis.2017.02.013","volume":"1863","author":"TJV Bichell","year":"2017","unstructured":"Bichell, T. J. V. et al. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington\u2019s disease mouse model. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 1596\u20131604 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"14169_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1039\/d0mt00081g","volume":"12","author":"AC Pfalzer","year":"2020","unstructured":"Pfalzer, A. C. et al. Huntington\u2019s disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice. Met. Integr. Biometal Sci. 12, 1118\u20131130 (2020).","journal-title":"Met. Integr. Biometal Sci."},{"key":"14169_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2021.09.002","author":"JM Wilcox","year":"2021","unstructured":"Wilcox, J. M. et al. YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes. Neurotoxicology https:\/\/doi.org\/10.1016\/j.neuro.2021.09.002 (2021).","journal-title":"Neurotoxicology"},{"key":"14169_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103266","volume":"65","author":"EB Johnson","year":"2021","unstructured":"Johnson, E. B. et al. Altered iron and myelin in premanifest Huntington\u2019s Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study. EBioMedicine 65, 103266 (2021).","journal-title":"EBioMedicine"},{"key":"14169_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077023","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. Iron accumulates in Huntington\u2019s disease neurons: protection by deferoxamine. PLoS ONE 8, e77023 (2013).","journal-title":"PLoS ONE"},{"key":"14169_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","volume":"33","author":"M-C Boll","year":"2008","unstructured":"Boll, M.-C., Alcaraz-Zubeldia, M., Montes, S. & Rios, C. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem. Res. 33, 1717\u20131723 (2008).","journal-title":"Neurochem. Res."},{"key":"14169_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1042\/BST0380552","volume":"38","author":"SL Hands","year":"2010","unstructured":"Hands, S. L., Mason, R., Sajjad, M. U., Giorgini, F. & Wyttenbach, A. Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington\u2019s disease. Biochem. Soc. Trans. 38, 552\u2013558 (2010).","journal-title":"Biochem. Soc. Trans."},{"key":"14169_CR19","doi-asserted-by":"crossref","unstructured":"Safety, tolerability, and efficacy of PBT2 in Huntington\u2019s disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 14, 39\u201347 (2015).","DOI":"10.1016\/S1474-4422(14)70262-5"},{"key":"14169_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/nu9040343","volume":"9","author":"M Wisniewska","year":"2017","unstructured":"Wisniewska, M. et al. Copper to zinc ratio as disease biomarker in neonates with early-onset congenital infections. Nutrients 9, 343 (2017).","journal-title":"Nutrients"},{"key":"14169_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-nutr-071714-034419","volume":"35","author":"KJ Horning","year":"2015","unstructured":"Horning, K. J., Caito, S. W., Tipps, K. G., Bowman, A. B. & Aschner, M. Manganese is essential for neuronal health. Annu. Rev. Nutr. 35, 71\u2013108 (2015).","journal-title":"Annu. Rev. Nutr."},{"issue":"107","key":"14169_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s007020050026","volume":"1996","author":"HJ Stuerenburg","year":"2000","unstructured":"Stuerenburg, H. J. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson\u2019s disease. J. Neural Transm. Vienna Austria 1996(107), 321\u2013329 (2000).","journal-title":"J. Neural Transm. Vienna Austria"},{"key":"14169_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101152","volume":"63","author":"M Scholefield","year":"2020","unstructured":"Scholefield, M., Unwin, R. D. & Cooper, G. J. S. Shared perturbations in the metallome and metabolome of Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and dementia with Lewy bodies: A systematic review. Ageing Res. Rev. 63, 101152 (2020).","journal-title":"Ageing Res. Rev."},{"key":"14169_CR24","doi-asserted-by":"publisher","first-page":"41316","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo, A. et al. Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington disease. Sci. Rep. 7, 41316 (2017).","journal-title":"Sci. Rep."},{"key":"14169_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012030","volume":"5","author":"RS Chung","year":"2010","unstructured":"Chung, R. S. et al. The native copper- and zinc- binding protein metallothionein blocks copper-mediated a\u03b2 aggregation and toxicity in rat cortical neurons. PLoS ONE 5, e12030 (2010).","journal-title":"PLoS ONE"},{"key":"14169_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/toxics2020327","volume":"2","author":"M Manto","year":"2014","unstructured":"Manto, M. Abnormal copper homeostasis: Mechanisms and roles in neurodegeneration. Toxics 2, 327\u2013345 (2014).","journal-title":"Toxics"},{"key":"14169_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2006.03.025","volume":"176","author":"A Becaria","year":"2006","unstructured":"Becaria, A. et al. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J. Neuroimmunol. 176, 16\u201323 (2006).","journal-title":"J. Neuroimmunol."},{"key":"14169_CR28","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist, M. et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J. Exp. Med. 205, 1869\u20131877 (2008).","journal-title":"J. Exp. Med."},{"key":"14169_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-3940(89)90565-X","volume":"103","author":"J Kardos","year":"1989","unstructured":"Kardos, J., Kov\u00e1cs, I., Haj\u00f3s, F., K\u00e1lm\u00e1n, M. & Simonyi, M. Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability. Neurosci. Lett. 103, 139\u2013144 (1989).","journal-title":"Neurosci. Lett."},{"key":"14169_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1523\/JNEUROSCI.3699-04.2005","volume":"25","author":"ML Schlief","year":"2005","unstructured":"Schlief, M. L., Craig, A. M. & Gitlin, J. D. NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J. Neurosci. Off. J. Soc. Neurosci. 25, 239\u2013246 (2005).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"14169_CR31","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.180165","volume":"8","author":"Y-T Hsu","year":"2018","unstructured":"Hsu, Y.-T., Chang, Y.-G. & Chern, Y. Insights into GABAAergic system alteration in Huntington\u2019s disease. Open Biol. 8, 180165 (2018).","journal-title":"Open Biol."},{"key":"14169_CR32","unstructured":"HDClarity-Protocol-2020\u201310-R1.pdf."},{"key":"14169_CR33","unstructured":"HDClarity_LabManual_V5.0_2021_0105.pdf."},{"key":"14169_CR34","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00415-015-7900-7","volume":"262","author":"D Liu","year":"2015","unstructured":"Liu, D. et al. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level. J. Neurol. 262, 2691\u20132698 (2015).","journal-title":"J. Neurol."},{"key":"14169_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney, J. B., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F. & Myers, R. H. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann. Neurol. 41, 689\u2013692 (1997).","journal-title":"Ann. Neurol."},{"key":"14169_CR36","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","volume":"89","author":"SA Schobel","year":"2017","unstructured":"Schobel, S. A. et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology 89, 2495\u20132502 (2017).","journal-title":"Neurology"},{"key":"14169_CR37","unstructured":"Research tools & reagents | CHDI Foundation. https:\/\/chdifoundation.org\/research-tools-reagents\/."},{"key":"14169_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2011.01.003","volume":"303","author":"I Hozumi","year":"2011","unstructured":"Hozumi, I. et al. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95\u201399 (2011).","journal-title":"J. Neurol. Sci."},{"key":"14169_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.109820","volume":"188","author":"F Patti","year":"2020","unstructured":"Patti, F. et al. CSF neurotoxic metals\/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset. Environ. Res. 188, 109820 (2020).","journal-title":"Environ. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14169-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:48:16Z","timestamp":1669337296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14169-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10373"}}